Skip to content

Analytical research on the histopathological morphology of solid tumors with fusion genes

Analytical research on the histopathological morphology of solid tumors with fusion genes

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500099078
Enrollment
Unknown
Registered
2025-03-18
Start date
2025-04-10
Completion date
Unknown
Last updated
2025-03-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

solid tumor

Interventions

RTK fusion negative group:NA
RTK fusion group:NA

Sponsors

Renji Hospital affiliated to Shanghai Jiaotong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Patients within the age range of 18 to 75 years, male or female; 2. Patients diagnosed with malignant solid tumors by histopathology in our hospital since 2010; 3. Patients who have undergone standard treatment and whose outcomes are known; 4. Patients who have adequate pathological tissue samples;

Exclusion criteria

Exclusion criteria: 1. Patients who have multiple tumors or those having other untreated malignant tumors; 2. Patients diagnosed with hemolymph system tumors; 3. Patients lacking detailed histopathological diagnostic reports and routine clinical follow-up data; 4. Patients lacking sufficient tissue samples or whose sample quality fails to meet the requisite standards;

Design outcomes

Primary

MeasureTime frame
RTK fusion;specificity;Sensitivity;

Countries

China

Contacts

Public ContactZebing Liu

Renji Hospital affiliated to Shanghai Jiaotong University School of Medicine

18719@renji.com+86 21 68383349

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026